Direct costs of chronic obstructive pulmonary disease among managed care patients.
Dalal
Anand A
AA
US Health Outcomes, GlaxoSmithKline, Research Triangle Park, Durham, NC 27709, USA. anand.a.dalal@gsk.com
Christensen
Laura
L
Liu
Fang
F
Riedel
Aylin A
AA
D000328:Adult; D000368:Aged; D000553:Ambulatory Care / Q000191:economics; D017046:Cost Savings; D003422:Critical Care / Q000191:economics; D019992:Databases as Topic; D016527:Drug Costs; D004636:Emergency Service, Hospital / Q000191:economics; D005260:Female; D017048:Health Care Costs; D005102:Health Expenditures; D006801:Humans; D007344:Insurance Claim Reporting; D007902:Length of Stay / Q000191:economics; D008297:Male; D008329:Managed Care Programs / Q000191:economics*; D008875:Middle Aged; D010343:Patient Admission / Q000191:economics; D029424:Pulmonary Disease, Chronic Obstructive / Q000191:economics* / Q000628:therapy*; D019141:Respiratory System Agents / Q000191:economics / Q000627:therapeutic use; D012189:Retrospective Studies; D014481:United States
D019141:Respiratory System Agents
health care cost; health expenditure; lung diseases; managed care